FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to ophthalmology. Acute blood serum and lachrymal fluid of a patient with uveitis are analysed for prostaglandin E2 concentration with calculating a ratio of blood serum prostaglandin E2 concentration to lachrymal fluid E2 prostaglandin E2 concentration. The value within 0.54-2.93 makes to diagnose rheumatoid arthritis, while the value 8.3-26.0 shows Marie-Strumpell disease.
EFFECT: method provides more frequent diagnosis of rheumatic uveites.
4 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR UVEITIS IN RHEUMATOID ARTHRITIS AND MARIE-STRUMPELL DISEASE | 2009 |
|
RU2415439C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR UVEITIS IN MARIE-STRUMPELL DISEASE AND RHEUMATOID ARTHRITIS | 2011 |
|
RU2450276C1 |
METHOD FOR DIAGNOSING RHEUMATIC UVEITIS CASES | 2006 |
|
RU2314534C1 |
METHOD FOR PREDICTING UVEITIS DEVELOPMENT COURSE IN THE CASES OF SYSTEMIC OR SYNDROMIC DISEASES | 1999 |
|
RU2157541C1 |
METHOD FOR DIAGNOSING ETIOLOGY OF UVEITIS AND PREDICTING NATURE OF COURSE | 2021 |
|
RU2755700C1 |
METHOD FOR PREDICTING EXACERBATION OF CHRONIC UVEITIS IN MEN WITH ANKYLOSING SPONDYLITIS | 2022 |
|
RU2782116C1 |
PROGNOSIS METHOD OF UVEITIS DEVELOPMENT IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS | 2016 |
|
RU2613056C1 |
METHOD FOR PREDICTION OF CLINICAL COURSES OF UVEITES ASSOCIATED WITH RHEUMATIC DISEASES IN CHILDREN, ACCOMPANYING BASIC THERAPY BY TUMOUR NECROSIS FACTOR ALPHA | 2011 |
|
RU2479848C1 |
METHOD FOR PREDICTING THE FLOW OF RHEUMATOID UVEITIS | 2005 |
|
RU2287164C1 |
METHOD FOR DETERMINING THE NEED FOR PRESCRIBING ANTIBIOTIC THERAPY FOR UVEITIS | 2021 |
|
RU2762492C1 |
Authors
Dates
2011-03-10—Published
2009-12-08—Filed